These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30857749)

  • 21. gamma-Substituted bis(pivaloyloxymethyl)ester analogues of fosmidomycin and FR900098.
    Kurz T; Behrendt C; Pein M; Kaula U; Bergmann B; Walter RD
    Arch Pharm (Weinheim); 2007 Dec; 340(12):661-6. PubMed ID: 17994605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substitution of the phosphonic acid and hydroxamic acid functionalities of the DXR inhibitor FR900098: an attempt to improve the activity against Mycobacterium tuberculosis.
    Andaloussi M; Lindh M; Björkelid C; Suresh S; Wieckowska A; Iyer H; Karlén A; Larhed M
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5403-7. PubMed ID: 21824775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibacterial and antitubercular activity of fosmidomycin, FR900098, and their lipophilic analogs.
    Uh E; Jackson ER; San Jose G; Maddox M; Lee RE; Lee RE; Boshoff HI; Dowd CS
    Bioorg Med Chem Lett; 2011 Dec; 21(23):6973-6. PubMed ID: 22024034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New N-arylamino biquinoline derivatives: synthesis, antimicrobial, antituberculosis, and antimalarial evaluation.
    Shah NM; Patel MP; Patel RG
    Eur J Med Chem; 2012 Aug; 54():239-47. PubMed ID: 22652224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A second target of the antimalarial and antibacterial agent fosmidomycin revealed by cellular metabolic profiling.
    Zhang B; Watts KM; Hodge D; Kemp LM; Hunstad DA; Hicks LM; Odom AR
    Biochemistry; 2011 May; 50(17):3570-7. PubMed ID: 21438569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alkoxycarbonyloxyethyl ester prodrugs of FR900098 with improved in vivo antimalarial activity.
    Ortmann R; Wiesner J; Reichenberg A; Henschker D; Beck E; Jomaa H; Schlitzer M
    Arch Pharm (Weinheim); 2005 Jul; 338(7):305-14. PubMed ID: 15996004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 7-chloroquinoline-isatin conjugates: antimalarial, antitubercular, and cytotoxic evaluation.
    Raj R; Biot C; Carrère-Kremer S; Kremer L; Guérardel Y; Gut J; Rosenthal PJ; Forge D; Kumar V
    Chem Biol Drug Des; 2014 May; 83(5):622-9. PubMed ID: 24341638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of chain length and unsaturation on Mtb Dxr inhibition and antitubercular killing activity of FR900098 analogs.
    Jackson ER; San Jose G; Brothers RC; Edelstein EK; Sheldon Z; Haymond A; Johny C; Boshoff HI; Couch RD; Dowd CS
    Bioorg Med Chem Lett; 2014 Jan; 24(2):649-53. PubMed ID: 24360562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, and X-ray crystallographic studies of α-aryl substituted fosmidomycin analogues as inhibitors of Mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate reductoisomerase.
    Andaloussi M; Henriksson LM; Więckowska A; Lindh M; Björkelid C; Larsson AM; Suresh S; Iyer H; Srinivasa BR; Bergfors T; Unge T; Mowbray SL; Larhed M; Jones TA; Karlén A
    J Med Chem; 2011 Jul; 54(14):4964-76. PubMed ID: 21678907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, antimalarial and antitubercular activity of acetylenic chalcones.
    Hans RH; Guantai EM; Lategan C; Smith PJ; Wan B; Franzblau SG; Gut J; Rosenthal PJ; Chibale K
    Bioorg Med Chem Lett; 2010 Feb; 20(3):942-4. PubMed ID: 20045640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arylmethyl substituted derivatives of Fosmidomycin: synthesis and antimalarial activity.
    Schlüter K; Walter RD; Bergmann B; Kurz T
    Eur J Med Chem; 2006 Dec; 41(12):1385-97. PubMed ID: 17055117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis, and application of novel triclosan prodrugs as potential antimalarial and antibacterial agents.
    Mishra S; Karmodiya K; Parasuraman P; Surolia A; Surolia N
    Bioorg Med Chem; 2008 May; 16(10):5536-46. PubMed ID: 18434169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo synergy of fosmidomycin, a novel antimalarial drug, with clindamycin.
    Wiesner J; Henschker D; Hutchinson DB; Beck E; Jomaa H
    Antimicrob Agents Chemother; 2002 Sep; 46(9):2889-94. PubMed ID: 12183243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthetic Fosmidomycin analogues with altered chelating moieties do not inhibit 1-deoxy-d-xylulose 5-phosphate Reductoisomerase or Plasmodium falciparum growth in vitro.
    Chofor R; Risseeuw MD; Pouyez J; Johny C; Wouters J; Dowd CS; Couch RD; Van Calenbergh S
    Molecules; 2014 Feb; 19(2):2571-87. PubMed ID: 24566322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Total synthesis of cyclomarins A, C and D, marine cyclic peptides with interesting anti-tuberculosis and anti-malaria activities.
    Barbie P; Kazmaier U
    Org Biomol Chem; 2016 Jul; 14(25):6036-54. PubMed ID: 27241518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance to the antimicrobial agent fosmidomycin and an FR900098 prodrug through mutations in the deoxyxylulose phosphate reductoisomerase gene (dxr).
    Armstrong CM; Meyers DJ; Imlay LS; Freel Meyers C; Odom AR
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5511-9. PubMed ID: 26124156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-hydroxamate inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXR): A critical review and future perspective.
    Kesharwani S; Sundriyal S
    Eur J Med Chem; 2021 Mar; 213():113055. PubMed ID: 33303239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and bioactivity of β-substituted fosmidomycin analogues targeting 1-deoxy-D-xylulose-5-phosphate reductoisomerase.
    Chofor R; Sooriyaarachchi S; Risseeuw MD; Bergfors T; Pouyez J; Johny C; Haymond A; Everaert A; Dowd CS; Maes L; Coenye T; Alex A; Couch RD; Jones TA; Wouters J; Mowbray SL; Van Calenbergh S
    J Med Chem; 2015 Apr; 58(7):2988-3001. PubMed ID: 25781377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disulfide prodrugs of albitiazolium (T3/SAR97276): synthesis and biological activities.
    Caldarelli SA; Hamel M; Duckert JF; Ouattara M; Calas M; Maynadier M; Wein S; Périgaud C; Pellet A; Vial HJ; Peyrottes S
    J Med Chem; 2012 May; 55(10):4619-28. PubMed ID: 22591034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel reverse thia-analogs of fosmidomycin: Synthesis and antiplasmodial activity.
    Lienau C; Gräwert T; Alves Avelar LA; Illarionov B; Held J; Knaab TC; Lungerich B; van Geelen L; Meier D; Geissler S; Cynis H; Riederer U; Buchholz M; Kalscheuer R; Bacher A; Mordmüller B; Fischer M; Kurz T
    Eur J Med Chem; 2019 Nov; 181():111555. PubMed ID: 31382119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.